Administration of IGF-I decreased seizure severity and hippocampal neurogenesis, which ameliorated hippocampal neurodegeneration and protected against cognitive deficits, in an experimental animal model of temporal lobe epilepsy (16). This evidence concerns the gene IGF1 and temporal lobe epilepsy.